{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:01:03Z","timestamp":1758906063097},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioconjugate Chem."],"published-print":{"date-parts":[[1998,5,1]]},"DOI":"10.1021\/bc970192w","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T05:17:43Z","timestamp":1027660663000},"page":"372-381","source":"Crossref","is-referenced-by-count":13,"title":["Role of Cross-Linking Agents in Determining the Biochemical and Pharmacokinetic Properties of Mgr6\u2212Clavin Immunotoxins"],"prefix":"10.1021","volume":"9","author":[{"given":"Franco","family":"Dosio","sequence":"first","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Adobati","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Canevari","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Brusa","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"De Santis","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Parente","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Pignanelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella R. M.","family":"Negri","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Colnaghi","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Cattel","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy, Divisione di Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy, and Dipartimento di Biotecnologie, Menarini Ricerche Sud, Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[1998,4,16]]},"reference":[{"key":"bc970192wb00001\/bc970192wb00001_1","volume-title":"A phase-I study of an anti-CD5 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. Blood 89, 403\u2212410","author":"Engert A.","year":"1997"},{"key":"bc970192wb00002\/bc970192wb00002_1","volume-title":"The emerging role of immunotoxins in leukemia and lymphoma. Ann. Oncol. 8 (Suppl. 1), 139\u2212146","author":"Winkler U.","year":"1997"},{"key":"bc970192wb00003\/bc970192wb00003_1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1997.15.2.723","volume":"15","author":"Lynch T. J.","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"bc970192wb00004\/bc970192wb00004_1","volume-title":"Advances in immunotoxin biology and therapy:\u2009 a summary of the Fourth International Symposium on Immunotoxins. Cancer Res. 56, 926\u2212932","author":"Frankel A. E.","year":"1996"},{"key":"bc970192wb00005\/bc970192wb00005_1","volume-title":"Immunotoxins. Cell 47, 641\u2212644","author":"Pastan I.","year":"1986"},{"key":"bc970192wb00006\/bc970192wb00006_1","volume-title":"Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 339, 1195\u22121196","author":"Falini B.","year":"1992"},{"key":"bc970192wb00007\/bc970192wb00007_1","first-page":"15","volume":"1","author":"Blakey D. C.","year":"1988","journal-title":"Antibody, Immunoconjugates, Radiopharm."},{"key":"bc970192wb00008\/bc970192wb00008_1","doi-asserted-by":"crossref","DOI":"10.1002\/jps.2600830218","volume":"83","author":"Dosio F.","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"bc970192wb00009\/bc970192wb00009_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1432-1033.1989.tb14511.x","volume":"178","author":"Conde F. P.","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"bc970192wb00010\/bc970192wb00010_1","volume-title":"Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma mAb. Cancer Immunol. Immunother. 26, 114\u2212120","author":"Orlandi R.","year":"1988"},{"key":"bc970192wb00011\/bc970192wb00011_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(97)00333-5","volume":"407","author":"Rathore D.","year":"1997","journal-title":"FEBS Lett."},{"key":"bc970192wb00012\/bc970192wb00012_1","volume":"257","author":"Endo Y.","year":"1982","journal-title":"J. Biol. Chem."},{"key":"bc970192wb00013\/bc970192wb00013_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1432-1033.1996.0272u.x","volume":"239","author":"Parente D.","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"bc970192wb00014\/bc970192wb00014_1","doi-asserted-by":"crossref","unstructured":"Centis, F., Tagliabue, E., Uppungumduri, S., Pellegrini, R., Martignone, S., Mastroianni, A., Menard, S., and Colnaghi, M. I. (1992) p185 Her2\/neup epitope mapping with murine monoclonal antibodies.Hybridoma 11, 267\u2212276.","DOI":"10.1089\/hyb.1992.11.267"},{"key":"bc970192wb00015\/bc970192wb00015_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.2181668","volume":"248","author":"Di Fiore P. P.","year":"1990","journal-title":"Science"},{"key":"bc970192wb00016\/bc970192wb00016_1","volume-title":"Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy. Cancer 75, 2147\u22122152","author":"Felip E.","year":"1995"},{"key":"bc970192wb00017\/bc970192wb00017_1","volume-title":"Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res. 52, 6310\u22126317","author":"Wels W.","year":"1992"},{"key":"bc970192wb00018\/bc970192wb00018_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 89","author":"Batra J. K.","year":"1992"},{"key":"bc970192wb00019\/bc970192wb00019_1","volume-title":"Immunotoxins to the HER-2 oncogene product:\u2009 functional and ultrastructural analysis of their cytotoxic activity. Cancer Immunol. Immunother. 39, 318\u2212324","author":"Di Lazzaro C.","year":"1994"},{"key":"bc970192wb00020\/bc970192wb00020_1","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.jbchem.a133849","volume":"91","author":"Masuho Y.","year":"1982","journal-title":"J. Biochem."},{"key":"bc970192wb00021\/bc970192wb00021_1","volume-title":"Fate of an antibody-ricin A chain conjugate administered to normal rats. Biochem. Pharmacol. 35, 417\u2212423","author":"Worrel N. R.","year":"1986"},{"key":"bc970192wb00022\/bc970192wb00022_1","volume":"79","author":"Thorpe P. E.","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"bc970192wb00023\/bc970192wb00023_1","volume-title":"New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability. Bioconjugate Chem. 8, 327\u2212337","author":"Arpicco S.","year":"1997"},{"key":"bc970192wb00024\/bc970192wb00024_1","volume-title":"Enhanced stability in vitro and in vivo of immunoconjugate prepared with 5-methyl-2-iminothiolane. Bioconjugate Chem. 5, 248\u2212256","author":"Carrol S. F.","year":"1994"},{"key":"bc970192wb00025\/bc970192wb00025_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)30438-6","volume":"253","author":"Higgins W.","year":"1978","journal-title":"J. Biol. Chem."},{"key":"bc970192wb00026\/bc970192wb00026_1","first-page":"73","volume":"132","author":"Duncan R. J. S.","year":"1983","journal-title":"Anal. Biochem."},{"key":"bc970192wb00027\/bc970192wb00027_1","volume-title":"Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma. Blood 81, 2263\u22122271","author":"Grossbard M. L.","year":"1993"},{"key":"bc970192wb00028\/bc970192wb00028_1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1993.11.4.726","volume":"11","author":"Grossbard M. L.","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"bc970192wb00029\/bc970192wb00029_1","volume-title":"Treatment of advanced solid tumors with immunotoxin LMB-1:\u2009 an antibody linked to Pseudomonas exotoxin. Nat. Med. 2, 350\u2212354","author":"Pai H. L.","year":"1996"},{"key":"bc970192wb00030\/bc970192wb00030_1","volume-title":"vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40. Blood 89, 4493\u22124500","author":"Francisco J. A.","year":"1997"},{"key":"bc970192wb00031\/bc970192wb00031_1","volume-title":"Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice. Cancer Immunol. Immunother. 35, 373\u2212380","author":"Brusa P.","year":"1992"},{"key":"bc970192wb00032\/bc970192wb00032_1","volume-title":"An immunotoxin prepared with blocked ricin:\u2009 a natural plant toxin adapted for therapeutical use. Cancer Res. 51, 6236\u22126242","author":"Lambert J. M.","year":"1991"},{"key":"bc970192wb00033\/bc970192wb00033_1","volume-title":"Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu\/c-erbB-2 protein. Cell Biophys. 24\u221225, 209\u2212218","author":"Dougall W. C.","year":"1994"},{"key":"bc970192wb00034\/bc970192wb00034_1","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.2910550122","volume":"55","author":"Tecce R.","year":"1993","journal-title":"Int. J. Cancer"},{"key":"bc970192wb00035\/bc970192wb00035_1","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.2910600120","volume":"60","author":"Wels W.","year":"1995","journal-title":"Int. J. Cancer"},{"key":"bc970192wb00036\/bc970192wb00036_1","first-page":"63","volume":"155","author":"Strocchi P.","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"bc970192wb00037\/bc970192wb00037_1","volume-title":"Clinical use of immunotoxins. Monoclonal antibodies conjugated to protein toxins. Immunol. Allergy Clin. North Am. 11, 359\u2212365","author":"Rybak S. M.","year":"1991"},{"key":"bc970192wb00038\/bc970192wb00038_1","doi-asserted-by":"crossref","DOI":"10.1016\/0192-0561(95)00068-D","volume":"17","author":"Benigni F.","year":"1995","journal-title":"Int. J. Immunopharmacol."},{"key":"bc970192wb00039\/bc970192wb00039_1","volume-title":"Hepatotoxicity of immunotoxins made by saporin, a ribosome inactivating protein from Saponaria officinalis. Virchows Arch. 53, 259\u2212271","author":"Stirpe F.","year":"1987"},{"key":"bc970192wb00040\/bc970192wb00040_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)38981-0","volume":"260","author":"Lambert J. M.","year":"1985","journal-title":"J. Biol. Chem."},{"key":"bc970192wb00041\/bc970192wb00041_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0022-1759(90)90251-P","volume":"135","author":"Cumber A. J.","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"bc970192wb00042\/bc970192wb00042_1","volume-title":"Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B. Anal. Biochem. 160, 440\u2212446","author":"Knowles P. P.","year":"1987"},{"key":"bc970192wb00043\/bc970192wb00043_1","doi-asserted-by":"crossref","DOI":"10.1016\/0022-1759(95)00036-A","volume":"182","author":"Dhanabal M.","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"bc970192wb00044\/bc970192wb00044_1","volume-title":"Immunotoxins","author":"Wawrzynczak E. J.","year":"1988"},{"key":"bc970192wb00045\/bc970192wb00045_1","volume-title":"Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab\u2018)2 fragment. Tumor Biol. 15, 175\u2212183","author":"Masuda K.","year":"1994"},{"key":"bc970192wn00001\/bc970192wn00001_1","volume-title":"immunotoxins","author":"Abbreviations"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/bc970192w","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T14:28:33Z","timestamp":1680791313000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/bc970192w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,16]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5,1]]}},"alternative-id":["10.1021\/bc970192w"],"URL":"https:\/\/doi.org\/10.1021\/bc970192w","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4,16]]}}}